Registry for Ambulant Therapy With RAS-Inhibitors in Hypertension-patients in Germany
Status:
Completed
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
In Germany nearly half of the population present elevated values of blood pressure, with - as
a result of lifestyle factors and a growing average age - further increasing numbers.
Consequences of arterial hypertension may be cardiovascular diseases, cerebrovascular events,
and renal insufficiency. Thus, hypertension therapy focuses on the reduction of these
complications.
The aims of the 3A-registry are the characterization of outpatients with hypertension, their
diagnostic procedures and medical treatment (esp. with renin inhibitors), therapy compliance
and success, clinical events, and an assessment of overall guideline adherence in the
treatment of these patients.
Patients fulfilling the relevant criteria are enrolled and followed up by their general
practitioner or medical specialist.